Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ReShape Lifesciences (RSLS)

ReShape Lifesciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RSLS
DateTimeSourceHeadlineSymbolCompany
01/04/202421:05GlobeNewswire Inc.ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
28/03/202412:31GlobeNewswire Inc.ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
04/03/202413:31GlobeNewswire Inc.ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
26/02/202421:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
22/02/202413:31GlobeNewswire Inc.ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
24/01/202413:31GlobeNewswire Inc.ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
18/01/202421:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
16/01/202423:11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RSLSReShape Lifesciences Inc
05/01/202421:14Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RSLSReShape Lifesciences Inc
20/12/202313:31GlobeNewswire Inc.ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership AlternativesNASDAQ:RSLSReShape Lifesciences Inc
12/12/202321:05GlobeNewswire Inc.ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEXNASDAQ:RSLSReShape Lifesciences Inc
29/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
21/11/202313:06GlobeNewswire Inc.ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross ProceedsNASDAQ:RSLSReShape Lifesciences Inc
08/11/202321:05GlobeNewswire Inc.ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction PlanNASDAQ:RSLSReShape Lifesciences Inc
06/11/202313:31GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
13/10/202321:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
05/10/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
03/10/202314:23Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RSLSReShape Lifesciences Inc
29/09/202317:30GlobeNewswire Inc.ReShape Lifesciences® Announces Pricing of $3.0 Million Public OfferingNASDAQ:RSLSReShape Lifesciences Inc
27/09/202322:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:RSLSReShape Lifesciences Inc
22/09/202321:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
22/09/202313:31GlobeNewswire Inc.ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVINASDAQ:RSLSReShape Lifesciences Inc
21/09/202313:31GlobeNewswire Inc.ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
19/09/202313:31GlobeNewswire Inc.ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon SystemNASDAQ:RSLSReShape Lifesciences Inc
14/09/202313:31GlobeNewswire Inc.ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ DeviceNASDAQ:RSLSReShape Lifesciences Inc
25/08/202321:41Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:RSLSReShape Lifesciences Inc
07/08/202322:26Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RSLSReShape Lifesciences Inc
07/08/202321:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RSLSReShape Lifesciences Inc
07/08/202321:05GlobeNewswire Inc.ReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
03/08/202321:05GlobeNewswire Inc.ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate UpdateNASDAQ:RSLSReShape Lifesciences Inc
 Showing the most relevant articles for your search:NASDAQ:RSLS